AU2014290598B2 - Azaindole compounds, synthesis thereof, and methods of using the same - Google Patents
Azaindole compounds, synthesis thereof, and methods of using the same Download PDFInfo
- Publication number
- AU2014290598B2 AU2014290598B2 AU2014290598A AU2014290598A AU2014290598B2 AU 2014290598 B2 AU2014290598 B2 AU 2014290598B2 AU 2014290598 A AU2014290598 A AU 2014290598A AU 2014290598 A AU2014290598 A AU 2014290598A AU 2014290598 B2 AU2014290598 B2 AU 2014290598B2
- Authority
- AU
- Australia
- Prior art keywords
- methyl
- pct
- hydrogen
- compound
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IAUZIBOJWUSMRD-UHFFFAOYSA-N CCCNC(c1c[n](Cc2nccc(OCC(F)(F)F)c2C)c2cccnc12)=O Chemical compound CCCNC(c1c[n](Cc2nccc(OCC(F)(F)F)c2C)c2cccnc12)=O IAUZIBOJWUSMRD-UHFFFAOYSA-N 0.000 description 1
- KUWABBHSSROSGS-UHFFFAOYSA-N Cc(c(C)ncn1)c1OC Chemical compound Cc(c(C)ncn1)c1OC KUWABBHSSROSGS-UHFFFAOYSA-N 0.000 description 1
- JTKXBRVKVZAUDR-UHFFFAOYSA-N Cc(ccc(OC)c1C[n]2c3cccnc3c(C(NCCF)=O)c2)c1F Chemical compound Cc(ccc(OC)c1C[n]2c3cccnc3c(C(NCCF)=O)c2)c1F JTKXBRVKVZAUDR-UHFFFAOYSA-N 0.000 description 1
- CBLLYWJCMCRHFU-UHFFFAOYSA-N Cc1cc([n](Cc2ncnc(C)c2C)cc2C(NCC3CC3)=C)c2nc1 Chemical compound Cc1cc([n](Cc2ncnc(C)c2C)cc2C(NCC3CC3)=C)c2nc1 CBLLYWJCMCRHFU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3196CH2013 | 2013-07-17 | ||
| IN3196/CHE/2013 | 2013-07-17 | ||
| PCT/US2014/046100 WO2015009525A1 (en) | 2013-07-17 | 2014-07-10 | Azaindole compounds, synthesis thereof, and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014290598A1 AU2014290598A1 (en) | 2016-02-11 |
| AU2014290598B2 true AU2014290598B2 (en) | 2018-11-08 |
Family
ID=51261257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014290598A Active AU2014290598B2 (en) | 2013-07-17 | 2014-07-10 | Azaindole compounds, synthesis thereof, and methods of using the same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9163020B2 (enExample) |
| EP (1) | EP3021947B1 (enExample) |
| JP (1) | JP6366709B2 (enExample) |
| KR (1) | KR102301753B1 (enExample) |
| CN (1) | CN105636646B (enExample) |
| AU (1) | AU2014290598B2 (enExample) |
| CA (1) | CA2918487C (enExample) |
| EA (1) | EA028611B1 (enExample) |
| ES (1) | ES2644025T3 (enExample) |
| WO (1) | WO2015009525A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201512197A (zh) * | 2013-08-30 | 2015-04-01 | Hoffmann La Roche | 吡咯并吡啶或吡唑并吡啶衍生物 |
| GB201317363D0 (en) * | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
| US11173113B2 (en) | 2017-12-06 | 2021-11-16 | Prollergy Corporation | Composition and method for reducing allergic response |
| RU2702224C2 (ru) * | 2018-03-29 | 2019-10-07 | Общество С Ограниченной Ответственностью "Мт-Медикалс" | Производные фенил формамидина, обладающие антимикобактериальной активностью |
| KR20210021042A (ko) * | 2018-06-15 | 2021-02-24 | 카딜라 핼쓰캐어 리미티드 | 포유동물 감염 치료를 위한 신규한 화합물 |
| WO2020188405A1 (en) * | 2019-03-20 | 2020-09-24 | Foundation For Neglected Disease Research | Benzimidazoles derivatives as anti-tuberculosis agents |
| CN111393435A (zh) * | 2020-03-16 | 2020-07-10 | 青岛吉澳医药科技有限公司 | 氮杂吲哚酰胺类化合物及其制备方法和用途 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011113606A1 (en) * | 2010-03-18 | 2011-09-22 | Institut Pasteur Korea | Anti-infective compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| BRPI0812594A2 (pt) * | 2007-08-10 | 2015-06-23 | Lundbeck & Co As H | Composto ou sal ou hidrato do mesmo, composição farmacêutica, métodos para modulação da atividade de um receptor p2x7, para tratamento de uma condição responsiva á modulação do receptor p2x7 em um paciente, para inibição de morte de células gangliônicas retinais em um paciente, para determinação da presença ou ausência de receptor p2x7 em uma amostra, preparação farmacêutica acondicionada, e, uso de um composto ou sal ou hidrato do mesmo. |
-
2014
- 2014-07-10 KR KR1020167004150A patent/KR102301753B1/ko active Active
- 2014-07-10 AU AU2014290598A patent/AU2014290598B2/en active Active
- 2014-07-10 EA EA201690227A patent/EA028611B1/ru unknown
- 2014-07-10 WO PCT/US2014/046100 patent/WO2015009525A1/en not_active Ceased
- 2014-07-10 CN CN201480046182.4A patent/CN105636646B/zh active Active
- 2014-07-10 US US14/327,784 patent/US9163020B2/en active Active
- 2014-07-10 EP EP14745305.4A patent/EP3021947B1/en active Active
- 2014-07-10 ES ES14745305.4T patent/ES2644025T3/es active Active
- 2014-07-10 JP JP2016526988A patent/JP6366709B2/ja active Active
- 2014-07-10 CA CA2918487A patent/CA2918487C/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011113606A1 (en) * | 2010-03-18 | 2011-09-22 | Institut Pasteur Korea | Anti-infective compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3021947A1 (en) | 2016-05-25 |
| CA2918487A1 (en) | 2015-01-22 |
| AU2014290598A1 (en) | 2016-02-11 |
| CN105636646A (zh) | 2016-06-01 |
| BR112016000712A2 (pt) | 2022-03-22 |
| CA2918487C (en) | 2021-08-03 |
| JP2016530242A (ja) | 2016-09-29 |
| WO2015009525A1 (en) | 2015-01-22 |
| US9163020B2 (en) | 2015-10-20 |
| EA201690227A1 (ru) | 2016-07-29 |
| JP6366709B2 (ja) | 2018-08-01 |
| CN105636646B (zh) | 2017-12-19 |
| KR20160058757A (ko) | 2016-05-25 |
| KR102301753B1 (ko) | 2021-09-15 |
| ES2644025T3 (es) | 2017-11-27 |
| EP3021947B1 (en) | 2017-08-23 |
| EA028611B1 (ru) | 2017-12-29 |
| US20150025087A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014290598B2 (en) | Azaindole compounds, synthesis thereof, and methods of using the same | |
| US20240207300A1 (en) | Combination therapies including myt1 inhibitors | |
| TWI694076B (zh) | 三唑并嘧啶化合物及其用途 | |
| US20250270197A1 (en) | Ribocil c antibiotics effective for gram-negative pathogens | |
| US10822339B2 (en) | Pyrrolopyrimidine five-membered azacyclic derivative and application thereof | |
| TWI580668B (zh) | Ｂ型肝炎抗病毒劑 | |
| US20250387379A1 (en) | Aryl-aniline and heteroaryl-aniline compounds for treatment of skin cancers | |
| EP4233834A2 (en) | Aryl-aniline and heteroaryl-aniline compounds for treatment of birthmarks | |
| US12479850B2 (en) | Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereof | |
| KR20160128456A (ko) | 이미다조옥사진 화합물에 의한 항종양 효과 증강제 | |
| US20220280509A1 (en) | Aza-quinoline compounds and uses thereof | |
| US20220204509A1 (en) | Pyrimido five-membered heterocyclic compound and use thereof as mutant idh2 inhibitor | |
| CN110461837A (zh) | 新型吡咯并吡啶衍生物、其制备方法及用途 | |
| US20250127780A1 (en) | Imidazo[4,5-b]pyridine and pyrazolo[1,5-a]pyrimidine derivatives as sik modulators for the treatment of rheumatoid arthritis | |
| US11072591B2 (en) | Tetrazole compounds and their use in the treatment of tuberculosis | |
| JP2025520237A (ja) | ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物 | |
| EP3250205B1 (en) | Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis | |
| JP2024528073A (ja) | 有機ピリジン－ピラゾール化合物及びその使用 | |
| CZ309884B6 (cs) | Substituovaný purin, jeho použití a farmaceutický přípravek ho obsahující | |
| BR112016000712B1 (pt) | Compostos de azaindol, síntese dos mesmos e métodos de uso dos mesmos | |
| US20260001898A1 (en) | Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereof | |
| US20070213339A1 (en) | Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |